Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide

Autor: Nerma Zahiragic, Mohamed Alboraie, Daniela Reis, Suzane K. Ono, Marina Biryukova, Rakesh Kochhar, Won Kim, Mohamed El Kassas, Ling Yang, Agustina Rodil, Jacob George, Narendra Dhaka, Way Siow, Caridad Ruenes Domech, Federico Sáez-Royuela, Nadja Sivac-Burina, Mercy Karoney, Alberto Queiroz Farias, Wenfang Gui, Vasily Isakov, Johannes Kluwe, Yuanjie Yu, John Chen Hsiang, Prem Harichander Thurairajah, Fernando Bessone, Ramon Bataller, Fatma Some, Julio Vorobioff, A. Sidney Barritt, Ester Badia-Aranda, Josepmaria Argemi, Chaoqun Zhang, Helena Cortez-Pinto, Meritxell Ventura-Cots, Enrique Arús-Soler, Mariana A. Nabeshima Pharm, Sanjin Spreckic, Shiyun Tan, Ahmad Alfadhli, Andrew Wandera, Zaily Dorta Guiridi, Pedro Miguel Marques da Costa, Christoph Scheurich, Edna Solange Dos Santos Traquino, Marlen Castellanos Fernández, Flair José Carrilho, Mohamed Yacoub, Neil D. Shah, Pengbo Wu, Juan G. Abraldes, Azra Husic-Selimovic, Teo Eng-Kiong
Přispěvatelé: Repositório da Universidade de Lisboa
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Clin Gastroenterol Hepatol
Popis: © 2019 by the AGA Institute
Background & aims: Despite recent advances in treatment of viral hepatitis, liver-related mortality is high, possibly owing to the large burden of advanced alcohol-related liver disease (ALD). We investigated whether patients with ALD are initially seen at later stages of disease development than patients with hepatitis C virus (HCV) infection or other etiologies. Methods: We performed a cross-sectional study of 3453 consecutive patients with either early or advanced liver disease (1699 patients with early and 1754 with advanced liver disease) seen at 17 tertiary care liver or gastrointestinal units worldwide, from August 2015 through March 2017. We collected anthropometric, etiology, and clinical information, as well as and model for end-stage liver disease scores. We used unconditional logistic regression to estimate the odds ratios for evaluation at late stages of the disease progression. Results: Of the patients analyzed, 81% had 1 etiology of liver disease and 17% had 2 etiologies of liver disease. Of patients seen at early stages for a single etiology, 31% had HCV infection, 21% had hepatitis B virus infection, and 17% had nonalcoholic fatty liver disease, whereas only 3.8% had ALD. In contrast, 29% of patients seen for advanced disease had ALD. Patients with ALD were more likely to be seen at specialized centers, with advanced-stage disease, compared with patients with HCV-associated liver disease (odds ratio, 14.1; 95% CI, 10.5-18.9; P < .001). Of patients with 2 etiologies of liver disease, excess alcohol use was associated with 50% of cases. These patients had significantly more visits to health care providers, with more advanced disease, compared with patients without excess alcohol use. The mean model for end-stage liver disease score for patients with advanced ALD (score, 16) was higher than for patients with advanced liver disease not associated with excess alcohol use (score, 13) (P < .01). Conclusions: In a cross-sectional analysis of patients with liver disease worldwide, we found that patients with ALD are seen with more advanced-stage disease than patients with HCV-associated liver disease. Of patients with 2 etiologies of liver disease, excess alcohol use was associated with 50% of cases. Early detection and referral programs are needed for patients with ALD worldwide.
This study was funded by the National Institute of Alcohol Abuse and Alcoholism grants U01AA021908 and U01AA020821, a scholarship grant from the Spanish Association for the Study of the Liver (M.V.-C.), and a grants NSFC 81570530 and 81370550 from the National Natural Science Foundation of China (L.Y.).
Databáze: OpenAIRE
Externí odkaz: